Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti‐VEGF/TKI and immunotherapy
Nguyen H. Tran(Mayo Clinic), Jordi Bruix(Hospital Clínic de Barcelona), Christopher L. Hallemeier(Mayo Clinic in Arizona), Scott M. Thompson(Mayo Clinic), Sergio Muñoz(Hospital Clínic de Barcelona)
Cited by 80
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
|Gastroenterology|2016|1.8k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k